Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Adverse effects
Systematic review	38 people 2 RCTs in this analysis	Anticholinergic events with oral chlorpromazine (50–1800 mg/day) with oral haloperidol (2–100 mg/day) Absolute results not reported	Reported as not significant P value not reported		Not significant
Systematic review	28 people Data from 1 RCT	At least 1 adverse effect with oral chlorpromazine (50–1800 mg/day) with oral haloperidol (2–100 mg/day) Absolute results not reported	RR 0.92 95% CI 0.65 to 1.30		Not significant
Systematic review	29 people Data from 1 RCT	Hypertension with oral chlorpromazine (50–1800 mg/day) with oral haloperidol (2–100 mg/day) Absolute results not reported	RR 6.07 95% CI 0.32 to 116.33		Not significant
Systematic review	66 people 2 RCTs in this analysis	Hypotension with oral chlorpromazine (50–1800 mg/day) with oral haloperidol (2–100 mg/day) Absolute results not reported	RR 0.22 95% CI 0.04 to 1.24		Not significant
Systematic review	86 people 3 RCTs in this analysis	Sedation with oral chlorpromazine (50–1800 mg/day) with oral haloperidol (2–100 mg/day) Absolute results not reported	RR 0.35 95% CI 0.02 to 5.73		Not significant
Systematic review	37 people Data from 1 RCT	Galactorrhoea with oral chlorpromazine (50–1800 mg/day) with oral haloperidol (2–100 mg/day) Absolute results not reported	RR 1.88 95% CI 0.76 to 4.68		Not significant
Systematic review	48 people 2 RCTs in this analysis	Weight gain with oral chlorpromazine (50–1800 mg/day) with oral haloperidol (2–100 mg/day) Absolute results not reported	RR 0.11 95% CI 0.01 to 1.89		Not significant
Systematic review	287 people Data from 1 RCT	Weight loss with oral chlorpromazine (50–1800 mg/day) with oral haloperidol (2–100 mg/day) Absolute results not reported	RR 3 95% CI 0.73 to 12.39		Not significant
Systematic review	103 people 3 RCTs in this analysis	At least 1 extrapyramidal adverse effect with oral chlorpromazine (50–1800 mg/day) with oral haloperidol (2–100 mg/day) Absolute results not reported	RR 1.96 95% CI 0.93 to 4.10		Not significant
Systematic review	48 people 2 RCTs in this analysis	Skin photosensitivity with oral chlorpromazine (50–1800 mg/day) with oral haloperidol (2–100 mg/day) Absolute results not reported	RR 0.17 95% CI 0.02 to 1.3		Not significant
Systematic review	38 people Data from 1 RCT	Rash with oral chlorpromazine (50–1800 mg/day) with oral haloperidol (2–100 mg/day) Absolute results not reported	RR 3 95% CI 0.13 to 69.31		Not significant